SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-032311
Filing Date
2023-09-12
Accepted
2023-09-12 08:30:18
Documents
22
Period of Report
2023-09-12
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38143
2 ex99-1.htm EX-99.1 6794
3 ex99-1_001.jpg GRAPHIC 162829
4 ex99-1_002.jpg GRAPHIC 423999
5 ex99-1_003.jpg GRAPHIC 375145
6 ex99-1_004.jpg GRAPHIC 267948
7 ex99-1_005.jpg GRAPHIC 312693
8 ex99-1_006.jpg GRAPHIC 329475
9 ex99-1_007.jpg GRAPHIC 225385
10 ex99-1_008.jpg GRAPHIC 274359
11 ex99-1_009.jpg GRAPHIC 375087
  Complete submission text file 0001493152-23-032311.txt   4005018

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE hils-20230912.xsd EX-101.SCH 3030
13 XBRL LABEL FILE hils-20230912_lab.xml EX-101.LAB 34240
14 XBRL PRESENTATION FILE hils-20230912_pre.xml EX-101.PRE 22369
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3417
Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Hillstream BioPharma Inc. (Filer) CIK: 0001861657 (see all company filings)

IRS No.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41210 | Film No.: 231249078
SIC: 2834 Pharmaceutical Preparations